Antitumor antisense sequences directed against R1 and R2 components of ribonucleotide reductase
US6121000A · kind A · utility
34Cited by
6References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 11, 1999 |
| Grant date | Sep 19, 2000 |
| Priority date | — |
| Expiry date | Feb 11, 2019 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2310/111
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compounds and methods for modulating cell proliferation, preferably inhibiting the proliferation of tumor cells are described. Compounds that may be used to modulate cell proliferation include antisense oligonucleotides complementary to regions of the mammalian ribonucleotide reductase genes.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.